# FDA Inspection 1002322 - Ricola Usa, Inc. - February 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/ricola-usa-inc/14082d8d-764b-4371-91da-d15c9bb313ca
Source feed: FDA_Inspections

> FDA Inspection 1002322 for Ricola Usa, Inc. on February 21, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002322
- Company Name: Ricola Usa, Inc.
- Inspection Date: 2017-02-21
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1002322 - 2017-02-21](https://www.keypedia.com/records/fda_inspections/ricola-usa-inc/9d7e856d-980c-4bbd-8965-7716b9b01869)
- [FDA Inspection 749009 - 2011-10-12](https://www.keypedia.com/records/fda_inspections/ricola-usa-inc/862856cc-28b2-484f-93d8-d52fde6a8a49)

Company: https://www.keypedia.com/companies/ricola-usa-inc/d64182c7-af80-40cb-966f-3a4ba4d4e54e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c